B+
Bull case
20%
Probability
Target price
$16.08
Analysis reference price unavailable
Analysis 2026-02-26 · RankAlpha Sentiment AI
CMPS
COMPASS PathwaysFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Positive late-stage readouts, constructive FDA interactions, and payer traction could re-rate COMPASS toward analyst upside within 12 months.
Posture
Defensive
Lead driver
Value
What changed
3 setup hits (3d) with net bullish as of 2026-09-09.
What can break
Binary clinical trial/readout failure
Momentum
82
Value
41
Sentiment
15
Setup hits (3d)
3 · Net Bullish
AI TargetsBase $8.17 · Bull $16.08 · Bear $5.48Analysis 2026-02-26; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-02-26 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Bullish
Target $22.71
Why
Momentum82 · Δ7d -4.4
Value41 · Δ7d 0.0
Sentiment15 · Δ7d -1.3
So what
Weak posture (Net Bullish). Prioritize risk control and patience.
Confirming evidence
- • 3 setup hits (3d) with net bullish as of 2026-09-09.
- • Value remains the lead driver in the composite, 7D delta 0.0.
Contradictions & invalidation
- • Binary clinical trial/readout failure
- • Dilution and financing needs
- • Trial failures, regulatory setbacks, or dilutive financings would compress multiples and push the share price materially lower.
Catalyst clock
2026-05-27
Analyst re-ratings / coverage updates
Lead driver: Value · See fundamentals
Momentum
82
9% active weight
Current posture
7d trendSoftening
Δ7d
-4.4
Δ21d
-7.7
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
15
62% active weight
Current posture
7d trendSoftening
Δ7d
-1.3
Δ21d
+1.4
Why this grade
Composite grade F. Momentum 82.0 / Value 41.2 / Sentiment 15.1
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-02-26. Scenario method
Most likely
B
Base case
60%
Probability
Target price
$8.17
Analysis reference price unavailable
Analysis 2026-02-26 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$5.48
Analysis reference price unavailable
Analysis 2026-02-26 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$1.86B
Beta
1.93
Shares Out
135.72M
P/E (TTM) · Derived
-4.4
P/S (TTM)
-
P/FCF (TTM) · Derived
-9.57
Rev YoY
-
EPS YoY
+352.1%
Gross Margin
-
Op Margin
-
Net Debt
-$114.95M
Current Ratio
1.30
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data